{"name":"Celcuity Inc","slug":"celcuity-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxOVkc5TDJ1Nl9QNjRWN1pnUlBUWWRYRjdwbjhOaUo2NzVybk5odVhkQUtsb1QwNUxXc1B2Xy02NEljeEJkYndrVFVMUHlPczRRVW9Ya1p4Sm1MZHY1VnBNbzBSSEFBcmtDUXQzMnEzcFlZelg5ajVGWG5MLVJWMXB3Tml1TlZvSXhQT29XUk5ISGlxaFlzVE0yNFpuNHpsbVBoRDcxcDloY3JCU1UxR251QzhweGRNaExJZTlhMFpENnBrQWxQTzJ6c21RREpoSkVaWnc?oc=5","date":"2026-02-20","type":"deal","source":"GuruFocus","summary":"Avoro Capital Advisors LLC Acquires Significant Stake in Celcuit - GuruFocus","headline":"Avoro Capital Advisors LLC Acquires Significant Stake in Celcuit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8wFBVV95cUxQWVh1cWlqaW54Q3dEY1dkZnJwcEJKWVhkTjF1aUplRUl3cUMyWWt4MHV1VnFjdzVrYjJvREVSWVZlMnRQNHNzZTBjajlPM3c2TDBEd3BUNGZYdGdlYmdZcmxQLVpIc0NzTkRyUjlpM1ZmbDhuSEtCdUx3RHo5LXBHYkRJam1lVThZUW9uOVFSV2p6bzNOdkxDZ2xZT3EtVThJUXBUWlgzM2JjMVZlSTBURThOX19lMlhiY2R0ZVRzbVFuckFBVTlNS2htVjk5V1B2ZGJ6OUU4TUY5d0FpdjBCUzJqM19GNFZ0TjJtZldiMDZianM?oc=5","date":"2026-02-06","type":"pipeline","source":"The Globe and Mail","summary":"Director Sells 20,000 Celcuity Shares for $2.4 Million Following 933% Share Price Jump - The Globe and Mail","headline":"Director Sells 20,000 Celcuity Shares for $2.4 Million Following 933% Share Price Jump","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPbjRqeVFJazA4RlI4cC1QaXhwZHdoNjFIcThCckNlZ2xfc2NrLXp0SnhodmdkUFFZN05EWVJSbll2VDl5RUNEVjduWmVNOXlqV1hBM3R3OHBSZWp5M09pdjlFM2lYRV92aHlmNmNoMVBKYzhaNW5GTzhNRzNTSHdFaC1kb1FWMl92?oc=5","date":"2026-02-02","type":"pipeline","source":"Fierce Pharma","summary":"Top 10 most anticipated drug launches of 2026 - Fierce Pharma","headline":"Top 10 most anticipated drug launches of 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxPTDNxQ0JQd2pSLTBOaW5VUVlNOHV4blhGakdoNlgwWDVrMDE3VVh0Q0pDZF9HUkxsZmhEQ2dqSmlyNFVNNXJkRzgyUFBSV1E4S04yVnpaODdzYWpBTXFZblVObFNQVWttWjJld0E2bGd2NFQ0WUN5NXRBVnBZemZaWVdLVkczT2pNX2ljVFNuMllReVdFNjlaZUo3ak1NYVVIUFNrZEMtcWtsMmxZcS1nb1F1bmExU3JNWDlITXZIVzl0MkRZT3cySWlYQXVIb2lmZFI1Z0VKM2pmemwydEtSMg?oc=5","date":"2026-01-08","type":"pipeline","source":"globenewswire.com","summary":"The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech - globenewswire.com","headline":"The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxPdktMbFpGRzBuWklKaGw0MGxGRXp3LXRtRWh3WE5Hb0QwdGpEeVZUb1RMUE1nTVlHMEhWeVdYRnJtdm1SRE1Ga2xzMGRGX1Y4VVBpUm9XajRQa29BXzBITVNRVV9QLXNyOWd4aGxFa3BEbEprZ01xeklkQXVucmJ1RzQ1LVZsWUszd2k4QWxMb1NJLVM1Qkk0MXB1NXVCbFNOM2huV0ZVd0xONGV6UFFTdFRQWmtocDFfZm85ejhsRE1xdzgxVXlr?oc=5","date":"2026-01-01","type":"earnings","source":"Star Tribune","summary":"2025’s best-performing Minnesota public company stock is a biopharmaceutical firm with no revenue - Star Tribune","headline":"2025’s best-performing Minnesota public company stock is a biopharmaceutical firm with no revenue","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPd3Q0SEI5dENwVzA0OVM5MmZwSER0SUFPcnNWQl9QYzMyMHJDdXNPUGtWbWVUTUt3Y2dBc0kzN2F1T2FNaGJneFc0U1Y0NHJoU2d2RzJaMmtqMnBWX2U3MWF5YzNnWkMyVE42am51UUswZGpUak5rT2ZVM0Rpbi15anlMdmVra2RISDY2TTdMeDdRMGtVRkp4RkxtVm1ZRkVvaEFGRjZzelpDZHpsRlRN?oc=5","date":"2025-12-24","type":"pipeline","source":"Seeking Alpha","summary":"Celcuity: After Stellar 2025, I Predict More Success In 2026 And Beyond (NASDAQ:CELC) - Seeking Alpha","headline":"Celcuity: After Stellar 2025, I Predict More Success In 2026 And Beyond (NASDAQ:CELC)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxQNzZlMHM0Q2xXekRhYmxyMVlKTkFld1BVUE1IT3M2MzNDWmJmb0xOLS1QbXdCbXlnd2gxWEpMN2FhUVVFeUVqeXdpZjVDUmZHLTJXYWF3UEEyZC1pRE1zamF4WnBBMWFkQUo2c05hMnJabWxwemllTDhJcTF4bUI4RVdVTHk?oc=5","date":"2025-11-23","type":"pipeline","source":"finance.yahoo.com","summary":"Celcuity (CELC)’s Clinical Success and M&A Potential Underpin Wolfe Research’s Bullish View - finance.yahoo.com","headline":"Celcuity (CELC)’s Clinical Success and M&A Potential Underpin Wolfe Research’s Bullish View","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPa2MzZkNmZXpGR3lhd1c3SWFzTndjODBvWUpCVGNBRUg1RDJ5dXExeDhwbGMwOFJ1Smh0ZS1RZ3pGWGN3RVNQVUJKSlpvZ2hzbF9kdTJZTzI3a1ltdHhpbUFBN1YtR3VULXlTemZldk5VUWJfbTcyOFZ4UlRoM3RvanZkOXZRUzNxVlBtU1NSY24?oc=5","date":"2025-10-20","type":"pipeline","source":"Investor's Business Daily","summary":"Top 1% Celcuity Stock Shoots To Record High On Roche-Rivaling Breast Cancer Results - Investor's Business Daily","headline":"Top 1% Celcuity Stock Shoots To Record High On Roche-Rivaling Breast Cancer Results - Investor's Business Daily","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-09-30","type":"earnings","source":"simplywall.st","summary":"3 Growth Companies With High Insider Ownership Seeing Up To 63% Revenue Growth - simplywall.st","headline":"3 Growth Companies With High Insider Ownership Seeing Up To 63% Revenue Growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNUW5uOHVnRy03RXp3eThXYnd5dlh4R0cyc3hpZ0UtaXgxNEhNLU9ScS1Fa1dTQUhFY0J3d1psLW5nOC1CSXJKSC1QNGp2NXlBWHpXa3lqVzlWRW5mMXZLQjVqbWRZNnFzZ05OWUhaS1FjYXNkRzNDdkc2Y0R2WFpYaWZLVm82MVFQTW81QXpWSGdzMUdpbGVyMURUc0NFUld3ZEowM2xWaEQxZ2M?oc=5","date":"2025-07-28","type":"pipeline","source":"BioPharma Dive","summary":"Celcuity shares triple on late-stage results for breast cancer therapy - BioPharma Dive","headline":"Celcuity shares triple on late-stage results for breast cancer therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQRjhRVFdMYm9LWlViRDc5VDZDSzNVaUtmX1BYQVFlbWZLOGlqcXN0MDhZZ3pkS3FpbTlNakZIbHVvN2k4RVV0OXR0NnRQT0otNnpBNkdnNWdzeEM4RlN6N0k4WE15Z3BVemNlbXhWTmIzR3JsbG9KNmRuNnhnQ3NpTkxPTnVqUFFDSVctU1g3eVo0UDJLbm1hZEZfeVBXNTY5eDlybFhMQ3ZzelF2?oc=5","date":"2025-07-28","type":"regulatory","source":"Fierce Biotech","summary":"Celcuity's breast cancer combo hits primary endpoints, teeing up FDA filing - Fierce Biotech","headline":"Celcuity's breast cancer combo hits primary endpoints, teeing up FDA filing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxPbUJvb0hUUVI0MmZCc3p5SmNzajNYWlR5RzU5Y1FRbnJ2MEpsMjR1OUdyX0hEakNJVGFpWUtBQUxZWW5RZzFtS2I4NW1TZ2NvRklVU2d5YmZMYXhWT2JHSU5zelZ4aWFnRGZqQkN3X0NGbHQ5eTd4YkhCY2NvQ1d5SFN4bU9heTdaWjF4UHRZR1pfWEtLeHpXUDdjNlpmUmFuRjdhTndnMEVBeHhmUDlncElQSmVpSUhjR29oYmg1dEtfTDMwYnNZeFJMc0dTMGJLVXI5MU84aG1RYlE?oc=5","date":"2025-07-28","type":"pipeline","source":"Stocktwits","summary":"This Pharma Stock Rose 200% On Monday Morning And Retail Says Valuation Could Rise To $5B: Here’s Why - Stocktwits","headline":"This Pharma Stock Rose 200% On Monday Morning And Retail Says Valuation Could Rise To $5B: Here’s Why","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}